Microcap Ledger Karyopharm Therapeutics Inc. $KPTI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Newton, MA
- Fiscal year end
- December 31
- Shares outstanding
- 22,681,460 [10-Q 2026-08-13]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $68.50M | −$89.42M | −$47.66M | $54.98M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | $146.07M | −$196.04M | −$75.37M | $60.54M | [10-K 2026-02-13] |
| FY ended Dec 2024 | $145.24M | −$76.42M | −$127.49M | $62.48M | [10-K 2026-02-13] |
- Quarterly cash burn
- −$23.83M
- Cash runway Estimate
- ~6.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 125,314,506 | [10-Q 2024-11-05] |
| 2025-02-14 | 126,240,054 | [10-K 2025-02-19] |
| 2025-05-07 | 8,639,904 | [10-Q 2025-05-12] |
| 2025-08-06 | 8,671,278 | [10-Q 2025-08-11] |
| 2025-10-30 | 17,050,876,000 | [10-Q 2025-11-03] |
| 2026-02-05 | 18,343,968 | [10-K 2026-02-13] |
| 2026-05-07 | 22,662,943 | [10-Q 2026-05-14] |
| 2026-08-06 | 22,681,460 | [10-Q 2026-08-13] |
- Shelf registration
- S-3 filed 2026-05-04; declared effective 2026-05-14 [S-3 2026-05-04]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-01 | Abate Kristin | sell | 378 | $1.19 | [4 2026-10-02] |
| 2026-09-01 | Abate Kristin | sell | 19 | $2.02 | [4 2026-09-02] |
| 2026-07-28 | Poulton Stuart | sell | 189 | $7.10 | [4 2026-07-30] |
| 2026-05-21 | Oliger Christy J. | grant | 15,508 | — | [4 2026-05-26] |
| 2026-05-21 | Pakianathan Deepika | grant | 15,508 | — | [4 2026-05-26] |
| 2026-05-21 | Schor Chen | grant | 15,508 | — | [4 2026-05-26] |
| 2026-05-21 | Su Zhen | grant | 15,508 | — | [4 2026-05-26] |
| 2026-05-21 | Bohlin Garen G | grant | 15,508 | — | [4 2026-05-26] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-08 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-09-25 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-09-25 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-09-18 | 8-K | Change to security holder rights; Charter, bylaws or fiscal year change |
| 2026-09-11 | 8-K | Material agreement entered; Obligation accelerated; Unregistered sale of equity |
| 2026-09-04 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-31 | 8-K | Other events |
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Results of operations |
| 2026-08-12 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $KPTI
Email me when Karyopharm Therapeutics Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.